Canada Life’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.1M | Buy |
78,886
+3,668
| +5% | +$2.81M | 0.11% | 159 |
|
|
2025
Q4 | $58.1M | Sell |
75,218
-15,786
| -17% | -$10.7M | 0.1% | 165 |
|
|
2025
Q3 | $51M | Buy |
91,004
+3,910
| +4% | +$2.21M | 0.07% | 240 |
|
|
2025
Q2 | $45.8M | Sell |
87,094
-37,529
| -30% | -$20.9M | 0.07% | 242 |
|
|
2025
Q1 | $79.1M | Buy |
124,623
+3,758
| +3% | +$2.58M | 0.14% | 135 |
|
|
2024
Q4 | $86M | Sell |
120,865
-5,331
| -4% | -$4.47M | 0.15% | 122 |
|
|
2024
Q3 | $133M | Buy |
126,196
+6,105
| +5% | +$6.79M | 0.23% | 78 |
|
|
2024
Q2 | $126M | Buy |
120,091
+18,927
| +19% | +$18.3M | 0.24% | 77 |
|
|
2024
Q1 | $97.4M | Sell |
101,164
-10,824
| -10% | -$10.3M | 0.2% | 105 |
|
|
2023
Q4 | $97.8M | Sell |
111,988
-11,375
| -9% | -$9.37M | 0.21% | 91 |
|
|
2023
Q3 | $101M | Sell |
123,363
-236
| -0.2% | -$185K | 0.24% | 80 |
|
|
2023
Q2 | $89.3M | Sell |
123,599
-8,241
| -6% | -$6.35M | 0.21% | 95 |
|
|
2023
Q1 | $108M | Sell |
131,840
-12,386
| -9% | -$9.34M | 0.27% | 70 |
|
|
2022
Q4 | $105M | Sell |
144,226
-24,961
| -15% | -$18.4M | 0.28% | 72 |
|
|
2022
Q3 | $116M | Sell |
169,187
-7,467
| -4% | -$4.7M | 0.33% | 61 |
|
|
2022
Q2 | $105M | Buy |
176,654
+4,377
| +3% | +$2.85M | 0.28% | 67 |
|
|
2022
Q1 | $127M | Sell |
172,277
-1,637
| -0.9% | -$1.04M | 0.26% | 73 |
|
|
2021
Q4 | $110M | Buy |
173,914
+16,481
| +10% | +$10.1M | 0.23% | 82 |
|
|
2021
Q3 | $95.8M | Buy |
157,433
+4,654
| +3% | +$2.89M | 0.22% | 85 |
|
|
2021
Q2 | $85.3M | Sell |
152,779
-24,151
| -14% | -$12.2M | 0.19% | 102 |
|
|
2021
Q1 | $83.3M | Sell |
176,930
-12,222
| -6% | -$5.95M | 0.2% | 103 |
|
|
2020
Q4 | $91.2M | Buy |
189,152
+40,758
| +27% | +$22M | 0.17% | 127 |
|
|
2020
Q3 | $83M | Buy |
148,394
+18,273
| +14% | +$11.1M | 0.18% | 128 |
|
|
2020
Q2 | $80.7M | Buy |
130,121
+65,976
| +103% | +$37.4M | 0.19% | 125 |
|
|
2020
Q1 | $31.5M | Sell |
64,145
-16,507
| -20% | -$6.81M | 0.08% | 237 |
|
|
2019
Q4 | $30.1M | Buy |
80,652
+3,579
| +5% | +$1.2M | 0.07% | 306 |
|
|
2019
Q3 | $21.4M | Sell |
77,073
-7,237
| -9% | -$2.14M | 0.05% | 366 |
|
|
2019
Q2 | $26.4M | Buy |
84,310
+388
| +0.5% | +$129K | 0.06% | 322 |
|
|
2019
Q1 | $34.4M | Buy |
83,922
+17,957
| +27% | +$7.39M | 0.09% | 224 |
|
|
2018
Q4 | $23.8M | Buy |
65,965
+16,865
| +34% | +$6.17M | 0.07% | 275 |
|
|
2018
Q3 | $19.9M | Sell |
49,100
-7,559
| -13% | -$2.88M | 0.05% | 346 |
|
|
2018
Q2 | $19.5M | Buy |
56,659
+924
| +2% | +$289K | 0.05% | 356 |
|
|
2018
Q1 | $19.2M | Sell |
55,735
-15,436
| -22% | -$5.37M | 0.05% | 355 |
|
|
2017
Q4 | $26.7M | Buy |
71,171
+4,635
| +7% | +$1.88M | 0.06% | 289 |
|
|
2017
Q3 | $29M | Buy |
66,536
+11,529
| +21% | +$5.49M | 0.07% | 276 |
|
|
2017
Q2 | $27M | Sell |
55,007
-134
| -0.2% | -$58.6K | 0.07% | 280 |
|
|
2017
Q1 | $21.3M | Buy |
55,141
+458
| +0.8% | +$170K | 0.06% | 321 |
|
|
2016
Q4 | $20.1M | Sell |
54,683
-854
| -2% | -$325K | 0.06% | 317 |
|
|
2016
Q3 | $22.3M | Buy |
55,537
+1,410
| +3% | +$566K | 0.07% | 295 |
|
|
2016
Q2 | $18.9M | Buy |
54,127
+13,020
| +32% | +$5.01M | 0.06% | 326 |
|
|
2016
Q1 | $14.8M | Sell |
41,107
-8,397
| -17% | -$3.46M | 0.05% | 323 |
|
|
2015
Q4 | $26.9M | Buy |
49,504
+8,142
| +20% | +$4.41M | 0.1% | 216 |
|
|
2015
Q3 | $19.2M | Sell |
41,362
-50,988
| -55% | -$27.4M | 0.08% | 263 |
|
|
2015
Q2 | $47.1M | Sell |
92,350
-314
| -0.3% | -$153K | 0.16% | 142 |
|
|
2015
Q1 | $41.7M | Sell |
92,664
-3,037
| -3% | -$1.29M | 0.14% | 165 |
|
|
2014
Q4 | $39.3M | Buy |
95,701
+17,473
| +22% | +$6.87M | 0.13% | 180 |
|
|
2014
Q3 | $28.2M | Buy |
78,228
+41,085
| +111% | +$13.8M | 0.09% | 230 |
|
|
2014
Q2 | $10.5M | Sell |
37,143
-279
| -0.7% | -$82.7K | 0.03% | 415 |
|
|
2014
Q1 | $11.2M | Buy |
37,422
+1,108
| +3% | +$341K | 0.04% | 396 |
|
|
2013
Q4 | $10M | Buy |
36,314
+36,019
| +12,210% | +$10.4M | 0.04% | 413 |
|
|
2013
Q3 | $92K | Sell |
295
-17
| -5% | -$4.47K | ﹤0.01% | 986 |
|
|
2013
Q2 | $70K | Buy |
+312
| New | +$72.7K | ﹤0.01% | 648 |
|
Other funds holding REGN
VCM
N
Canada Life's REGN Position: Q1 2026 in Review
Canada Life increased its Regeneron Pharmaceuticals (REGN) stake by 4.9% in Q1 2026, buying an estimated $2.81M and bringing the position to 78,886 shares worth $61.1M. The position accounts for 0.11% of the portfolio, ranked #159.
Canada Life first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $133M in Q3 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Canada Life held 78,886 shares of Regeneron Pharmaceuticals worth $61.1M as of Q1 2026.
- Canada Life bought 3,668 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.81M.
- Regeneron Pharmaceuticals made up 0.11% of Canada Life's portfolio in Q1 2026, its #159 holding.
- Canada Life first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Canada Life's Regeneron Pharmaceuticals position peaked at $133M in Q3 2024.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.